LUPELIC owner Contact Information online
from Glaxo Group Limited
LUPELIC
US serial number:85128075
Application filling date:Sep. 13, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:May 17, 2011
Publication date:Mar. 01, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign foreign registration number:2441343
Foreign foreign registration date:Dec. 13, 2006
Foreign foreign application registration country:UNITED KINGDOM
Foreign foreign expiration date:Dec. 13, 2016
Goods and services:For: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive
Current owner owner name:Glaxo Group Limited
Current owner owner address:980 Great West Road
Brentford, Middlesex
UNITED KINGDOM
TW89GS
Current owner legal entity type:CORPORATION
Current owner state or country:UNITED KINGDOM
Attorney name:Christopher M. Hanes
Attorney email:trademarks@gsk.com
Attorney docket number:PRJ/7056097/
Attorney email authorized:Yes
Correspondent name address:Christopher M. Hanes
GLAXOSMITHKLINE
Five Moore Drive
Legal Global Trademarks, Mailstop: 5.5A
Research Triangle Park,
NORTH CAROLINA
UNITED STATES
27709-0183
Correspondent phone:919.483.2723
Correspondent email:trademarks@gsk.com
Correspondent fax:919-315-3023
Correspondent email authorized:Yes
Domestic representative name:Christopher M. Hanes
Domestic representative phone:919.483.2723
Domestic representative fax:919-315-3023
Domestic representative email:trademarks@gsk.com
Domestic representative email authorized LUPELIC:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (178) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (30) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 01, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
